Moneycontrol PRO
Open App

Coronavirus pandemic: Pharma body seeks govt intervention to end disruption caused by lockdown

IPA drew the attention of the government towards the mistreatment of pharmaceutical industry workers by police.

March 26, 2020 / 07:24 PM IST

The Indian Pharmaceutical Alliance (IPA) - the industry body representing large domestic pharmaceutical companies -  expressed concern over manufacturing and supply chain disruption owing to the ongoing lockdown imposed by the government across the country.

IPA drew the attention of the government towards the mistreatment of pharmaceutical industry workers by police. The group noted that workers in pharmaceutical manufacturing and supply chain were beaten up by police and vehicles transporting goods were stopped at checkpoints.

The pharma body urged the government to immediately resolve the issue by asking chief secretaries to direct the police department and district magistrates to follow government instructions. The authorities concerned should accept company identity cards issued to pharma sector employees. Moreover, employees in warehouses, C&F agents, pharmacists, and chemists should be recognised as part of pharma operations. Restrictions on the movement of goods and services to the pharma industry also should be eased.

The industry representatives also called for better coordination between states and inter-government authorities.

The government imposed a 21-day lockdown of the country starting from midnight of March 24 to slow down the spread of COVID-19. Only essential services are allowed to operate. However, the lack of coordination between states and government authorities is leading to disruption of even essential services like the pharma industry, which shouldn't stop making and distributing medicines.


COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
"There is ambiguity on the ground and it will be important to consider the challenges faced in pharmaceutical production, distribution and supply as essential goods and services. All employees engaged in this sector, like medical professionals, should continue to be involved in their respective

roles for manufacturing and distribution as it is fundamental to saving lives," IPA said in a letter to the government.

IPA brought to the government's notice the problems faced by drug manufacturing facilities as many units are being directed to be shut down by local authorities.

"We have been getting feedback from our companies that Maharashtra, Gujarat, Telangana and Andhra Pradesh are relatively better placed in production. However, operations are impacted in Goa, Baddi, Uttar Pradesh, Daman, Silvasa and Indore," IPA said in a letter addressed to various government agencies such as Prime Minister Office, Ministry of Home Affairs and Department of Pharmaceuticals.

The alliance also pointed out that the interstate employee movement from Punjab and Haryana to Baddi in Himachal Pradesh, which is a major manufacturing hub, took a hit. "Employees are scared to come to work due to fear, stoppage of movement and unpleasant incidents that have been reported," it added.

According to IPA, there are shortages of packing materials, protection gear like masks and gloves for workers in the factories, coal to operate boilers and absence of contractors and contractual workers to perform tasks like electric, civil, ducting work, maintenance of equipment, nitrogen supply and scrap movement.

On the distribution front, the pharma industry is unable to move the material from clearing and forwarding (C&F) agents to warehouses of stockists. The stockists are not able to work as they don't come under essential commodities and services.

"Even employees are not able to come to pharmacy and warehouses as they are being stopped by police. Fear has been induced by police and in some cases, employees are beaten up," IPA said.

The industry also said the transportation services are disrupted as vehicles carrying staff to handle critical deliveries are stopped and staff are not allowed to move for handling or deliveries, and in some cases have been beaten up by police. The industry expressed concerns about intra- and interstate transport hampered due to lack of coordination between authorities. Ports are functioning at low capacity and containers are not available.
Viswanath Pilla is a business journalist with 14 years of reporting experience. Based in Mumbai, Pilla covers pharma, healthcare and infrastructure sectors for Moneycontrol.
first published: Mar 26, 2020 07:24 pm
ISO 27001 - BSI Assurance Mark